Canadian Cannabis Market: Page 8

Aleafia Health Secures Health Canada License Amendment for Paris Production and Extraction Facility Phase II Expansion

The 30,000-square-foot expansion is entirely dedicated to the extraction, production, packaging and distribution of finished cannabis products.

Illinois Delays Awarding New Cannabis Dispensary Licenses, Canopy Growth Lays off 200 More Workers: Week in Review

This week, Illinois regulators planned to issue 75 adult-use dispensary licenses, but instead announced that they will now wait until the governor’s disaster proclamation expires.

Canopy Growth Lays Off 200 Additional Employees

In its latest phase of scaling back operations, the Canadian LP eliminated workers in Canada, the U.S. and the UK.

Aleafia Health’s AssureHome Delivery Provides Fast, Direct-to-Door Medical Cannabis Supply

The company has launched next-day distribution of medical cannabis products.

Aleafia Health Provides Update on Strategic Growth Initiatives

The company has has a successful transition to virtual clinic services with 3,300 remote patient consultations completed since March 16.

Canopy Growth Scales Back Operations

The Canadian licensed producer looks to slow down cash-burn as new CEO reviews costs.

Aphria Inc. Announces Net Cannabis Revenue Increases 65% From Prior Quarter and Fourth Consecutive Quarter of Positive Adjusted EBITDA

The company has provided updates on the COVID-19 impact and fiscal year 2020 guidance.

The Green Organic Dutchman Signs Letter of Intent with Quebec's SQDC

The company now has agreements in place with every province except PEI.

Aurora Cannabis Provides Update on Initiatives to Strengthen Liquidity, Business Transformation Plan and COVID-19 Operational Response

The company has strengthened its cash position with plans for additional flexibility given the current economic uncertainty.

DEA Deschedules Epidiolex, Senators Urge SBA to Extend Economic Assistance to Cannabis Businesses: Week in Review

Effective immediately, the DEA has descheduled GW Pharmaceuticals’ Epidiolex, which was initially listed under Schedule V following its approval in 2018.

Rubicon Organics Announces Sale of Washington Greenhouse, Strengthening of Balance Sheet and Strategic Exit from the U.S.

Proceeds from the sale of the greenhouse will strengthen the company’s balance sheet, providing working capital to ramp-up production and sales across Canada.

Ontario Allows Cannabis Retailers to Reopen with Delivery and In-Store Pick-Up Services

The province passed an emergency order allowing dispensaries to reopen after deeming them “non-essential” in an update last week.

Previous Page

Page 8 of 14

Next Page